• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STORZ MEDICAL AG D-ACTOR 100; RADIAL SHOCKWAVE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STORZ MEDICAL AG D-ACTOR 100; RADIAL SHOCKWAVE DEVICE Back to Search Results
Model Number 23300
Device Problem Use of Device Problem (1670)
Patient Problem Tinnitus (2103)
Event Date 10/05/2021
Event Type  Injury  
Manufacturer Narrative
No device problem found.Incident most likely due to misuse of device by non-healthcare professional.No ear protection was used, chosen energy settings were reportedly to high, and "simulated patient" was reportedly not asked for feedback regarding treatment intensity or pain / discomfort.
 
Event Description
During a device demonstration, a sales representative was treating a volunteer (a "mock patient" without pre-existing neck problems) next to the cervical spine (height c3-c4) with the radial shockwave device d-actor 100 with spine applicator tip 3 at 2.0 bar with 2000 shots.D-actor is a device for prescription use only under (21 cfr 801 subpart d), i.E., for use only by a licensed practitioner (i.E.Ifu intended exclusively for use by health care professional).The sales representative is not a licensed practitioner, nor a health care professional, so he should not have used the device on humans.The volunteer was not offered ear protection as recommended in the ifu.It has also been reported that even though the volunteer`s teeth were chattering during treatment, she has not been asked for feedback regarding treatment intensity or pain / discomfort.Apparently, the chosen energy level / patient positioning was not appropriate for that particular patient.As per ifu, treatment should always start at a low energy level that should be increased gradually during treatment.Furthermore, treatment was applied to the spinal column and/or vertebrae and the ifu asks users to take caution when treating these areas.The volunteer reported ringing in the ears immediately after treatment.Right ear ceased to ring after 24 hours, but left ear was still ringing after 8 days.Volunteer went to eent and was prescribed steroid medication (methylprednisone 4mg).No additional patient information could be obtained.The device has been tested and no problems were detected on performance or noise level.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
D-ACTOR 100
Type of Device
RADIAL SHOCKWAVE DEVICE
Manufacturer (Section D)
STORZ MEDICAL AG
lohstampfestrasse 8
taegerwilen, thurgau 8274
SZ  8274
Manufacturer Contact
markus huebscher
lohstampfestrasse 8
taegerwilen, thurgau 8274
SZ   8274
MDR Report Key12927541
MDR Text Key283497561
Report Number3002808188-2021-00001
Device Sequence Number1
Product Code ISA
UDI-Device Identifier07630039101060
UDI-Public(01)07630039101060(11)210609
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K173692
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Remedial Action Inspection
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Other
Device Model Number23300
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/25/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2021
Was Device Evaluated by Manufacturer? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age44 YR
Patient SexFemale
Patient Weight68 KG
-
-